These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 31343144)

  • 21. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin analogues for type 1 diabetes in children and adolescents.
    Galli-Tsinopoulou A; Stergidou D
    Drugs Today (Barc); 2012 Dec; 48(12):795-809. PubMed ID: 23243636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of insulin detemir.
    Kurtzhals P
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():14-20. PubMed ID: 17881328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
    Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
    Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal Dysphagia and Recurrent Aspiration From Treatment-Induced Neuropathy of Diabetes in an Adult Patient With Type 1 Diabetes.
    Oleynick C; Prosperi-Porta G; Wilson BJ
    Can J Diabetes; 2021 Mar; 45(2):105-107.e1. PubMed ID: 33046405
    [No Abstract]   [Full Text] [Related]  

  • 27. Intensive diabetes therapy and body weight: focus on insulin detemir.
    Bush MA
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():33-44. PubMed ID: 17881330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
    Caputo S; Maran A; Mannino D; Morano S; Lastoria G; Nicoziani P
    Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of basal insulin therapy on vascular endothelial function and adipokine profiles in people with Type 2 diabetes.
    Makino H; Tanaka A; Hosoda H; Koezuka R; Tochiya M; Ohata Y; Tamanaha T; Miyamoto Y; Kangawa K; Kishimoto I
    Diabet Med; 2016 Dec; 33(12):1737-1743. PubMed ID: 27150701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin analogues for recurrent severe hypoglycaemia.
    Knip M
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):529-30. PubMed ID: 24794702
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
    Robertson KJ; Schoenle E; Gucev Z; Mordhorst L; Gall MA; Ludvigsson J
    Diabet Med; 2007 Jan; 24(1):27-34. PubMed ID: 17227321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.
    Frier BM; Russell-Jones D; Heise T
    Diabetes Obes Metab; 2013 Nov; 15(11):978-86. PubMed ID: 23551900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons.
    Sanches AC; Correr CJ; Venson R; Pontarolo R
    Diabetes Res Clin Pract; 2011 Dec; 94(3):333-9. PubMed ID: 21992870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin analogues: place of detemir (levemir)].
    Dorchy H; Sternon J
    Rev Med Brux; 2006; 27(2):89-94. PubMed ID: 16736846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of basal insulins.
    Barnett AH
    Diabet Med; 2003 Nov; 20(11):873-85. PubMed ID: 14632712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Madenidou AV; Paschos P; Karagiannis T; Katsoula A; Athanasiadou E; Kitsios K; Bekiari E; Matthews DR; Tsapas A
    Ann Intern Med; 2018 Aug; 169(3):165-174. PubMed ID: 29987326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic patients from the Belgian PREDICTIVE Cohort.
    Preumont V; Buysschaert M; De Beukelaer S; Mathieu C
    Acta Clin Belg; 2009; 64(1):49-55. PubMed ID: 19317241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.
    Danne T; Lüpke K; Walte K; Von Schuetz W; Gall MA
    Diabetes Care; 2003 Nov; 26(11):3087-92. PubMed ID: 14578244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials.
    Palmer AJ; Roze S; Valentine WJ; Smith I; Wittrup-Jensen KU
    Curr Med Res Opin; 2004 Nov; 20(11):1729-46. PubMed ID: 15537473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.